You are viewing: Mexico Latent TB Testing Market analysis
Part of: Latent TB Testing Market (Global)

The Mexico Latent TB Testing Market was valued at $7.2 Million in 2024 and projected to reach to $10.3 Million by 2029, representing a compound annual growth rate of 7.5%. Mexico's latent TB testing market is positioned for sustained expansion through 2029, driven by government healthcare initiatives and increased awareness of tuberculosis prevention.

Mexico Latent TB Testing Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Mexico Latent TB Testing Market Trends and Insights

  • This expansion reflects Mexico's increasing focus on tuberculosis screening and prevention programs, driven by rising healthcare investments and improved diagnostic infrastructure.
  • Mexico's market growth rate of 7.5% CAGR outpaces the global average, indicating strong regional demand for latent TB detection solutions. The latent TB testing market in Mexico is supported by growing awareness of tuberculosis control initiatives and enhanced access to diagnostic technologies.
  • Mexico's healthcare sector is prioritizing early detection and treatment of latent TB infections to reduce progression to active disease.
  • Between 2024 and 2029, Mexico is expected to see significant adoption of advanced testing methodologies, including interferon-gamma release assays and tuberculin skin tests, as public health programs expand their screening capabilities. Mexico's market trajectory reflects broader Latin American trends toward improved TB management and preventive healthcare.
  • The country's commitment to WHO tuberculosis elimination targets is driving investment in diagnostic infrastructure and healthcare provider training, positioning Mexico as a key growth market for latent TB testing solutions in the region..

Key Market Statistics

  • CAGR (2024-2029) 7.5% CAGR
  • Market Size, 2024 ~USD 7.2 Million
  • Forecast, 2029 ~USD 10.3 Million
  • Country Mexico

Mexico Latent TB Testing Market Overview

Market Valuation Growth :

Mexico's latent TB testing market is valued at $7.2 million in 2024, with projections reaching $10.3 million by 2029, representing a robust 43% increase over the five-year forecast period.

Outpacing Global Growth :

Mexico's market CAGR of 7.5% significantly exceeds the global average of 5.8%, indicating accelerated adoption of latent TB diagnostic solutions within the country's healthcare system.

Healthcare Infrastructure Expansion :

Rising healthcare investments and improved diagnostic infrastructure across Mexico are driving increased accessibility to latent TB testing services, particularly in underserved regions.

Prevention-Focused Strategy :

Mexico's emphasis on tuberculosis screening and prevention programs reflects a strategic shift toward early detection and intervention, reducing active TB transmission rates.

Mexico Latent TB Testing Market Dynamics

  • The country's healthcare sector is investing in diagnostic infrastructure modernization, enabling broader access to latent TB testing across both urban and rural populations.
  • This expansion is supported by Mexico's commitment to WHO tuberculosis elimination targets and strengthened public health programs. The 7.5% CAGR reflects growing demand from healthcare providers, laboratories, and public health institutions seeking reliable diagnostic solutions.
  • Continued investment in healthcare technology, coupled with rising prevalence awareness and improved reimbursement policies, will sustain market momentum.
  • Mexico's strategic positioning within North America also facilitates access to advanced testing technologies and international best practices..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • CONMED Corporation

    Key Takeaways

    • Mexico's latent TB testing market is valued at $7.2 million in 2024 and is forecast to reach $10.3 million by 2029, representing a 7.5% CAGR.
    • Mexico's market growth rate significantly exceeds the global average of 5.8%, indicating strong regional demand and healthcare investment.
    • Mexico is prioritizing TB screening and prevention programs as part of broader public health initiatives aligned with WHO elimination targets.
    • Advanced diagnostic technologies, including IGRAs and TSTs, are expected to see increased adoption across Mexico's healthcare system through 2029.

    Latent TB Testing Market Report Scope

    Report Metric Details
    Base Year 2024
    Fastest Growing Segment HOUSEHOLD CONTACTS WITH PULMONARY TB (Application)
    Forecast Period 2024-2029
    Growth Rate CAGR of 5.8% from 2024 to 2029
    Largest Segment IGRA (Test Type)
    Market Size Base Year (Billions) ~USD 0.58 (2024)
    Revenue Forecast (Billions) ~USD 0.77 (2029)
    Segments Covered Test Type, Application, End User

    Mexico Latent TB Testing Market Report Segmentation

    3 segment dimensions are covered across the global market.

    By Test Type

    • Igra
    • Tst

    By Application

    • Household Contacts With Pulmonary Tb
    • Other Applications
    • People Living With Hiv

    By End User

    • Academic & Research Institutes
    • Diagnostic Laboratories
    • Hospitals & Clinics
    • Other End Users

    MEXICO: LATENT TB TESTING MARKET, BY END USER, 2022–2029

    Segment20222023202420252026202720282029CAGR (%)
    ACADEMIC & RESEARCH INSTITUTES0.330.390.40.410.430.450.480.515.2
    DIAGNOSTIC LABORATORIES4.114.885.155.475.876.346.917.558
    HOSPITALS & CLINICS1.391.621.681.761.851.972.112.276.2
    OTHER END USERS0.220.250.250.260.270.280.290.314.1
    TOTAL6.047.147.487.98.429.059.7910.647.3

    Target Audience

    • Diagnostic Equipment Manufacturers : Manufacturers need Mexico-specific market data to assess demand for latent TB testing platforms, understand infrastructure requirements, and develop localized product strategies for this high-growth market.
    • Healthcare Investment Firms : Investment professionals require detailed Mexico market forecasts and growth drivers to evaluate portfolio opportunities in diagnostic companies and healthcare infrastructure projects targeting TB prevention.
    • Public Health Organizations : Government health agencies and NGOs need market intelligence to align TB elimination programs with diagnostic capacity, plan resource allocation, and measure progress against prevention targets.
    • Laboratory Service Providers : Clinical laboratories and diagnostic centers require Mexico market insights to plan expansion, invest in testing capabilities, and position services to meet growing latent TB screening demand.
    • Healthcare Consultants & Analysts : Consulting firms and market analysts need comprehensive Mexico data to support client advisory services, competitive benchmarking, and strategic planning in the tuberculosis diagnostics sector.

    Reasons to Buy this Report

    • Market-Specific Growth Intelligence : Gain detailed insights into Mexico's 7.5% CAGR trajectory and understand the country-specific drivers differentiating it from global market trends, enabling targeted business strategy development.
    • Investment Decision Support : Access comprehensive valuation data ($7.2M to $10.3M forecast) to evaluate market entry opportunities, expansion potential, and ROI projections specific to Mexico's healthcare landscape.
    • Competitive Positioning Analysis : Understand Mexico's diagnostic infrastructure development and healthcare investment patterns to identify competitive advantages and market gaps for latent TB testing solutions.
    • Regulatory and Healthcare Context : Leverage Mexico-specific insights on prevention programs, healthcare policies, and diagnostic adoption patterns to align product development and market entry strategies effectively.
    • Regional Expansion Planning : Use Mexico market data as a foundation for broader Latin American expansion strategies, with clear benchmarks for market penetration and growth potential in comparable regions.

    Frequently asked questions

    What is the current size of Mexico's latent TB testing market?

    Mexico's latent TB testing market was valued at $7.2 million in 2024 and is projected to grow to $10.3 million by 2029.

    What is the expected growth rate for latent TB testing in Mexico?

    Mexico's latent TB testing market is expected to grow at a compound annual growth rate (CAGR) of 7.5% from 2024 to 2029.

    What factors are driving growth in Mexico's latent TB testing market?

    Growth in Mexico's latent TB testing market is driven by increased healthcare investments, improved diagnostic infrastructure, rising TB screening awareness, and alignment with WHO tuberculosis elimination targets.

    Which diagnostic technologies are most prevalent in Mexico's latent TB testing market?

    Mexico's latent TB testing market primarily utilizes interferon-gamma release assays (IGRAs) and tuberculin skin tests (TSTs), with increasing adoption of advanced methodologies through 2029.

    How does Mexico's market growth compare to global trends?

    Mexico's latent TB testing market CAGR of 7.5% significantly outpaces the global average of 5.8%, reflecting stronger regional demand and healthcare sector expansion.

    RESEARCH METHODOLOGY

    The study involved major activities in estimating the current market size for the latent TB testing market. Exhaustive secondary research was done to collect information on the latent TB testing industry. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the latent TB testing market.

    The four steps involved in estimating the market size are

    Secondary Research

    In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.

    Primary Research

    In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources were mainly industry experts from the core and related industries and preferred suppliers, manufacturers, distributors, service providers, technology developers, researchers, and organizations related to all segments of this industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts, C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information as well as assess prospects.

    The following is a breakdown of the primary respondents:

    Note 1: Others include sales managers, marketing managers, and product managers.

    Note 2: Companies are classified into tiers based on their total revenues. As of 2022/2023, Tier 1 = >USD 100 million, Tier 2 = USD 10 million to USD 100 million, and Tier 3 = < USD 10 million.

    To know about the assumptions considered for the study, download the pdf brochure

    COMPANY NAME DESIGNATION
    QIAGEN General Manager
    Revvity Area Sales Manager

    Market Size Estimation

    Both top-down and bottom-up approaches were used to estimate and validate the latent TB testing market's total size. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

    • The key players in the industry have been identified through extensive secondary research
    • The revenues generated by leading players operating in the latent TB testing market have been determined through primary and secondary research.
    • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

    The research methodology used to estimate the market size includes the following:

    Data Triangulation

    After arriving at the overall market size by applying the process mentioned above, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

    Market Definition

    Latent tuberculosis testing refers to diagnosing the infection by detecting an immune response to Mycobacterium tuberculosis antigens using either the tuberculin skin test (TST) or interferon-gamma release assays (IGRAs). These tests help identify dormant tuberculosis infections in individuals without active symptoms.

    Stakeholders

    • Senior Management
    • End User
    • Finance/Procurement Department  
    • R&D Department

    Report Objectives

    • To define, describe, segment, and forecast the global latent TB testing market, by test type, application, end user, and region
    • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
    • To analyze the micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall latent TB testing market
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To forecast the size of the market segments with respect to five regions, namely, North America, Europe, the Asia Pacific, Middle East & Africa, and Latin America
    • To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
    • To track and analyze company developments such as product launches & approvals, partnerships, acquisitions, agreements, and other developments
    • To benchmark players within the market using the proprietary Competitive Leadership Mapping framework, which analyzes market players on various parameters within the broad categories of business and product excellence

     

    Get the Full Latent TB Testing Market Report

    Full forecast, segment splits, and company analysis for all Latent TB Testing Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status